(https://t.me/covidvaccinevictims) If you would like to read Moderna-NIAID's own document of the Covid vaccine clinical trials protocol design you can do so here: https://www.modernatx.com/pipeline --------------------------------------------------------- Vaccine name: mRNA-1273 Efficacy: 94.5% Dose: 2 doses, 4 weeks apart Type: Muscle injection Storage: 30 days with refrigeration, 6 months at –4°F (–20°C) On Dec. 18., the F.D.A. gave emergency use authorization for a vaccine made by the Boston-based company Moderna. The Moderna vaccine is the second one authorized by the F.D.A., coming a week after the vaccine made by Pfizer and BioNTech. Like Pfizer and BioNTech, Moderna makes its vaccine from mRNA. In recent years, the company has tested mRNA vaccines for a number of diseases, but they have yet to bring one to market. Last January, they began developing a vaccine for the coronavirus. The United States government bankrolled Moderna’s efforts, providing nearly $1 billion in support. In partnership with National Institutes of Health, they found that the vaccine protects monkeys from the coronavirus. Last March, the scientists were the first to put a Covid-19 vaccine into human trials. After those studies yielded promising results, Phase 3 testing on 30,000 volunteers began on July 27. On Nov. 16, Moderna announced the first preliminary data from the trial, followed by the complete data on Nov. 30. The researchers estimated that the vaccine had an efficacy rate of 94.1 percent. While it’s not clear how long this efficacy will last, Moderna has found that after three months the trial participants still have a strong immune defense against the coronavirus. On Dec. 2, Moderna registered a trial to test the vaccine on adolescents between 12 and 18 years of age. In March, the company began testing the vaccine in babies and young children. Meanwhile, the company entered deals with several countries to supply the vaccine pending its approval. On Aug. 11 last year, the United States government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective. Additional negotiations have increased the agreement to 300 million doses by July 2021. On Nov. 25, the company reached an agreement with the European Commission to supply up to 160 million doses. Moderna has made similar deals with other countries including Canada, Japan, Qatar and South Korea. On Feb. 25, Moderna announced they were working to produce between 600 million and a billion doses for 2021. They are making investments to expand capacity up to 1.4 billion doses in 2022. In March, Moderna began a Phase 1 trial of a vaccine made specifically for the B.1.351 variant and a Phase 1 trial of a new, refrigerator-stable vaccine. Approved for use in: Switzerland. Emergency use in: Canada, European Union, Iceland, Israel, Mongolia, Norway, Qatar, Singapore, United Kingdom, United States, Vietnam. (Updated March 20th 2021 - https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html)

“An in-depth, scientific—yet hopeful and positive—look at how the brain and body work together . . . [Dr. Martha Herbert] has developed a new way of seeing autism.”—Library Journal After years of treating patients and analyzing scientific data, Harvard Medical School researcher and clinician Dr. Martha Herbert offers a revolutionary new view of autism and a transformative strategy for dealing with it. Autism, she concludes, is not a hardwired impairment programmed into a child’s genes and destined to remain fixed forever. Instead, it is the result of a cascade of events, many seemingly minor. And while other doctors may dismiss your child’s physical symptoms—the anxiety, sensory overload, sleeplessness, frequent illnesses or seizures—as coincidental or irrelevant, Dr. Herbert sees them as vital clues to what the underlying problems are, and how to help. Drawing from the newest research, technologies, and insights, as well as inspiring case studies of both children and adults, Dr. Herbert guides you toward restoring health and resiliency in your loved one with autism. Her specific recommendations aim to provide optimal nutrition, reduce toxic exposures, limit stress, and open the door to learning and creativity. As thousands of families who have cobbled together these solutions themselves already know, this program can have dramatic benefits—for your child with autism, and for you, your whole family, and perhaps your next baby as well. “Invaluable . . . a must-read . . . Dr. Martha Herbert gets it. She not only gets it, but she puts it out there in an awesome book so the rest of us can get it, too.”—Autism Watch “[Herbert] goes further than most autism specialists. Her impressive science background merges with common sense and even intuitive sense [making] complex scientific and medical materials seamlessly blend with a holistic viewpoint.”—Relieve Autism “Hope and practical guidance . . . With this easy-to-read book, parents can gain wisdom on how to guide your child to achieve a healthy and thriving life.”—Mom Central